Latest filing published 31 Oct 2007 for UROLOGIX INC, €2,805.
Insider track record
No signal scores available.
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -38.7%Entry US$1.63 · Close at T+365 US$1.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kirsten Doerfert: trading record in brief
All filings by Kirsten Doerfert on record concern Urologix Inc. In total, 4 filings cover trades dated 30 October 2007.
Purchases make up the whole of the open-market record (4 purchases, €8,581). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Half of the purchases are above €1,690 and half below. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -41.7%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 31 October 2007, reports an open-market purchase of €2,805 in Urologix Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kirsten Doerfert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$1.62Common StockSEC:0001362118-07-000073:0Canonical exit: 28 Jan 2008 (T+90)
- 200 shares@ US$1.65Common StockSEC:0001362118-07-000073:1Canonical exit: 28 Jan 2008 (T+90)
- 500 shares@ US$1.66Common StockSEC:0001362118-07-000073:2Canonical exit: 28 Jan 2008 (T+90)
- 4,300 shares@ US$1.67Common StockSEC:0001362118-07-000073:3Canonical exit: 28 Jan 2008 (T+90)
4 of 4 declarations
